Trial Profile
Retrospective single-center study of Posaconazole (PCZ) With Delayed-Release Tablets (DRT) in High-Risk Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2016
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Aspergillosis; Candidiasis; Mycoses; Oropharyngeal candidiasis
- Focus Pharmacokinetics
- 30 Dec 2016 New trial record